Orlando (Fla.) Health grew to a $10 billion organization in fiscal 2025 and posted a $345.7 million operating gain (3.5% margin) for the year ended Sept. 30 — down from the $525.1 million operating gain (7.3% margin) it reported the year prior.
Six things to know:
1. Orlando Health’s annual revenue rose nearly 38% year over year to $9.9 billion, driven by two major acquisitions completed in late 2024. These included a $963.5 million deal for Birmingham, Ala.-based Brookwood Baptist Health System and a $439 million purchase of three Florida hospitals from Steward Health Care.
2. Net patient service revenue increased 37.8% year over year to $8.5 billion. Total annual admissions rose 35%, and total outpatient visits jumped 43%, according to financial documents published Nov. 25.
3. Total operating expenses increased 44% to $9.6 billion, primarily due to the added cost structure from the acquisitions and higher labor and supply expenses. Salaries and benefits totaled $4.7 billion, while supply costs hit $2.1 billion.
4. After accounting for nonoperating items, such as $405 million in investment income, Orlando Health reported $727.5 million in net income for the year, down from $1.1 billion in fiscal 2024.
5. The system ended the fiscal year with $917.4 million in cash and cash equivalents. Capital expenditures included $1.1 billion in construction projects, with $1.4 billion more planned, primarily for emergency departments, bed towers and medical pavilions.
6. As of Sept. 30, 2025, Orlando Health had long-term debt of $4.1 billion and total net assets of $7.3 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
